SBC Medical Group Holdings Incorporated (SBC)

In January 2026, SBC announced a strategic investment with OrangeTwist, entering the U.S. market. In December 2025, the company authorized a $20 million share repurchase program and announced an updated capital strategy. In November 2025, SBC reported its Third Quarter 2025 financial results and announced its entry into the Thai market through a partnership with BLEZ. In September 2025, SBC launched new brands, "Neo Skin Clinic" and "Hada no Aozora Clinic," in Tokyo. In Q3 2025, the company experienced stabilized revenue growth, with expectations for renewed growth in early 2026, an increase in average revenue per customer by 5%, and a repeat customer rate of 72%. In December 2024, SBC Medical Group Co., Ltd. sold its shares in SBC Kijimadaira Resort Co., Ltd. and Skynet Academy Co., Ltd. to focus on its core medical services business.

Specific demand seasonality for SBC Medical Group Holdings, Inc.'s products and services is not explicitly detailed. Demand could be influenced by consumer trends, disposable income, and seasonal lifestyle changes. Increased market competition has impacted pricing, and revenue growth is expected to return in 2026.

SBC Medical Group Holdings, Inc. is a global healthcare management company providing management support services and products to cosmetic treatment centers, operating in healthcare services and commercial services. The company offers services to franchisee clinics, focusing on aesthetic medicine, including advertising, staff management, booking, housing assistance, clinic design, and medical consumables procurement. SBC offers a range of medical services, including aesthetic medicine, dermatology, dentistry, hair loss treatment, fertility treatment, ophthalmology, orthopedics, and regenerative medicine, along with surgical and non-surgical aesthetic treatments.

SBC Medical Group Holdings, Inc. has an international presence, providing management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company is expanding globally, particularly in the United States and Asia, through direct operations and medical tourism. In late 2025, SBC entered the Thai market through a partnership with BLEZ ASIA Co. Ltd. The company's headquarters are located in Irvine, California, USA, and Tokyo, Japan, with a clinic network of 282 clinics as of January 2026.

SBC Medical Group Holdings, Inc. has focused on strengthening its international reputation for quality and trust in medical care, expanding the market by making aesthetic medicine more accessible and differentiating itself through advanced treatments and competitive pricing. These efforts have led to an expansion in the number of clinics, increased repeat business, and enhanced customer loyalty.

Institutional investors own 60.82% of SBC Medical Group Holdings, Inc.'s stock, with major shareholders including Geode Capital Management LLC, SBI Securities Co. Ltd., and Millennium Management LLC. Yoshiyuki Aikawa, the Chairman and CEO, is the largest individual shareholder, owning 91.83% of the company's shares. Other significant owners include Zuu Co Ltd, Dustin M. Shindo, and Mehana Capital LLC.